Biochemical changes in Dementia disorders of Alzheimer type (AD/SDAT)

[1]  T. Magnusson,et al.  A procedure for the isolation of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from the same tissue sample using a single column of strongly acidic cation exchange resin. , 2009, Acta pharmacologica et toxicologica.

[2]  J. Coyle,et al.  Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.

[3]  W. Bondareff,et al.  Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia , 1982, Neurology.

[4]  S. Corkin.  Acetylcholine, aging and Alzheimer's disease Implications for treatment , 1981, Trends in Neurosciences.

[5]  M. Roth,et al.  SELECTIVE LOSS OF NEURONES OF ORIGIN OF ADRENERGIC PROJECTION TO CEREBRAL CORTEX (NUCLEUS LOCUS COERULEUS) IN SENILE DEMENTIA , 1981, The Lancet.

[6]  B. Johansson,et al.  Monoamine metabolites in successive samples of spinal fluid , 1981, Acta neurologica Scandinavica.

[7]  B. Winblad,et al.  Prevalence of dementia disorders in institutionalized Swedish old people THE WORK LOAD IMPOSED BY CARING FOR THESE PATIENTS , 1981, Acta psychiatrica Scandinavica.

[8]  P. Davies,et al.  Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile Dementia of the Alzheimer type , 1981, Neurobiology of Aging.

[9]  R. Katzman.,et al.  Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa , 1980, Nature.

[10]  P. Emson,et al.  Reduced corticol choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide , 1980, Brain Research.

[11]  B. Winblad,et al.  Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. , 1980, Life sciences.

[12]  P. Yates,et al.  Changes in the Monoamine Containing Neurones of the Human Cns in Senile Dementia , 1980, British Journal of Psychiatry.

[13]  L. Svennerholm,et al.  A procedure for the quantitative isolation of brain gangliosides. , 1980, Biochimica et biophysica acta.

[14]  Peter Davies,et al.  Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains , 1977, Brain Research.

[15]  J. Spillane,et al.  Selective vulnerability of neurones in organic dementia , 1977, Nature.

[16]  D. Bowen,et al.  NEOCORTICAL CHOLINERGIC NEURONS IN ELDERLY PEOPLE , 1977, The Lancet.

[17]  J. Meek,et al.  Aging-induced Changes in Acetylcholine and Serotonin Content of Discrete Brain Nuclei , 1977 .

[18]  G. Blessed,et al.  NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA , 1977, The Lancet.

[19]  P. Davies,et al.  SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.

[20]  D M Bowen,et al.  Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. , 1976, Brain : a journal of neurology.

[21]  F. Fonnum,et al.  A rapid radiochemical method for the determination of choline acetyltransferase , 1975, Journal of neurochemistry.

[22]  D. Bowen,et al.  Brain-decarboxylase activities as indices of pathological change in senile dementia. , 1974, Lancet.

[23]  J. Pearce.  Letter: Mental changes in Parkinsonism. , 1974, British medical journal.

[24]  M. Houslay,et al.  Allotopic properties of human brain monoamine oxidase. , 1973, Nature: New biology.

[25]  C. Atack.  The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay , 1973, British journal of pharmacology.

[26]  C. Finch,et al.  Catecholamine metabolism in the brains of ageing male mice. , 1973, Brain research.

[27]  J. Davis,et al.  Ageing, monoamines, and monoamine-oxidase levels. , 1972, Lancet.

[28]  H. Fibiger,et al.  Aging and brain enzymes. , 1971, Experimental gerontology.

[29]  P. Mcgeer,et al.  DISTRIBUTION OF TYROSINE HYDROXYLASE IN HUMAN AND ANIMAL BRAIN 1 , 1971, Journal of neurochemistry.

[30]  R. S. Stacey,et al.  5-hydroxytryptamine, noradrenaline, and dopamine in brainstem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal-gas poisoning. , 1969, Lancet.

[31]  C. Gottfries,et al.  The Investigation of Homovanillic Acid in the Human Brain and its Correlation to Senile Dementia , 1969, British Journal of Psychiatry.

[32]  P. Mcgeer,et al.  Some characteristics of brain tyrosine hydroxylase. , 1967, Canadian journal of biochemistry.

[33]  W. J. Nicholson,et al.  EFFECT OF MONOAMINE-OXIDASE INHIBITORS ON THE CONCENTRATIONS OF 5-HYDROXYTRYPTAMINE IN THE HUMAN BRAIN. , 1965, Lancet.

[34]  H. Kalmus,et al.  Senile Dementia. A Clinical, Sociomedical and Genetic Study. , 1964 .

[35]  R. Wurtman,et al.  A SENSITIVE AND SPECIFIC ASSAY FOR THE ESTIMATION OF MONOAMINE OXIDASE. , 1963, Biochemical pharmacology.

[36]  Å. Bertler,et al.  A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. , 1958, Acta physiologica Scandinavica.

[37]  S. Udenfriend,et al.  A fluorometric method for the estimation of tyrosine in plasma and tissues. , 1957, The Journal of laboratory and clinical medicine.

[38]  B. Winblad,et al.  Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism. , 1980, Advances in biochemical psychopharmacology.

[39]  A. Nordberg,et al.  Studies of muscarinic and nicotinic binding sites in brain. , 1980, Acta physiologica Scandinavica. Supplementum.

[40]  L. Svennerholm.  Gangliosides and synaptic transmission. , 1980, Advances in experimental medicine and biology.

[41]  P. Mandel,et al.  Structure and Function of Gangliosides , 1980, Advances in Experimental Medicine and Biology.

[42]  M. Bonati,et al.  BIOCHEMICAL CHANGES IN CENTRAL CATECHOLAMINERGIC NEURONS OF THE SENESCENT RATS , 1978 .

[43]  D. Bowen,et al.  Chemical pathology of this organic dementias. II. Quantitative estimation of cellular changes in post-mortem brains. , 1977, Brain : a journal of neurology.

[44]  D. Robinson.  Changes in monoamine oxidase and monoamines with human development and aging. , 1975, Federation proceedings.

[45]  A. Vernadakis.  Neuronal--glial interactions during development and aging. , 1975, Federation proceedings.

[46]  H. Hess,et al.  Microchemical pathology of the cerebral cortex in pre-senile dementias. , 1964, Transactions of the American Neurological Association.

[47]  L. Svennerholm,et al.  Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. , 1957, Biochimica et Biophysica Acta.